Japanese Pharmaceutical Marketing Company So-net M3 Estimates Double-digit Growth
This article was originally published in PharmAsia News
Executive Summary
Japanese pharmaceutical information provider So-net M3 reported April 23 that the company's net profit increased by 20 percent to ¥2.3 billion ($23.7 million), the company also increased dividends by ¥300 to ¥3000. For fiscal year 2009, M3 estimated another double-digit growth rate of 14 percent in net profit to ¥2.7 billion. So-net M3 has expanded marketing support service for Japanese domestic pharmaceutical companies; the company also is growing overseas businesses, mainly targeting the U.S. market. (Click here for more - Japanese language